AB0498 ASSOCIATION OF METABOLIC PATHWAY-RELATED SINGLE NUCLEOTIDE POLYMORPHISMS WITH ORAL METHOTREXATE TREATMENT OUTCOMES IN RHEUMATOID ARTHRITIS PATIENTS - Rahman, A. (Annals of the rheumatic diseases, 2024)
Keywords: Adverse events; Best practices; Comorbidity; Creatinine; Disease-modifying Drugs (DMARDs); Hypothyroidism; Metabolic pathways; Metabolism; Methotrexate; Methylenetetrahydrofolate reductase; Nausea; Outcome measures; Patients; Polymerase chain reaction; Polymorphism; Quality of life; Restriction fragment length polymorphism; Rheumatoid arthritis; Rheumatoid factor; Rheumatology; Scientific Abstracts; Single-nucleotide polymorphism; Outcome measures; Best practices; Disease-modifying Drugs (DMARDs)